PROTARA THERAPEUTIC INC (TARA)

US74365U1079 - Common Stock

2.91  +0.02 (+0.69%)

After market: 2.91 0 (0%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
0.000.000.000.000.00
Operating Expenses
43.61M37.54M47.49M34.44M15.25M
Research and Development
24.79M16.67M21.09M11.98M6.44M
Selling, General, and Administrative Expenses
18.49M20.63M26.40M22.46M8.82M
Operating Income
-43.61M-37.54M-47.49M-34.44M-15.25M
Interest Income/Expense
3.19M1.11M240.00K470.00K260.00K
Other Income/Expense
N/AN/AN/AN/A0.00
Non Recurring Items
N/A-29.52MN/AN/AN/A
Income Before Taxes
-40.42M-65.95M-47.25M-33.98M-14.99M
Income Tax
N/AN/AN/AN/AN/A
Net Income
-40.42M-65.95M-47.25M-33.98M-14.99M
EBITDA
-43.27M-37.29M-47.37M-34.34M-14.97M
 
Per Share Data
EPS Diluted Total Ops
-3.57-5.86-4.21-4.70-29.98
Non GAAP EPS
-3.57-3.99-4.21-4.73-30.15
 
Statistics
Profit Margin
N/AN/AN/AN/AN/A
Operating Profit Margin
N/AN/AN/AN/AN/A

All data in USD

Charts